Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis

NCT01177852 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Inflammation
Cough
Rhinitis

Interventions

DRUG: diphenhydramine + dropropizine + pseudoephedrine
DRUG: Dropropizine and fixed dose combination of pseudoephedrine hydrochloride + brompheniramine maleate (Dimetapp® elixir).

Sponsor

Ache Laboratorios Farmaceuticos S.A.